- Case report
- Open Access
A gastrointestinal stromal tumor with mesenteric and retroperitoneal invasion
© Engin et al; licensee BioMed Central Ltd. 2007
- Received: 23 March 2007
- Accepted: 24 October 2007
- Published: 24 October 2007
Gastrointestinal stromal tumors are rare visceral sarcomas arising in the gastrointestinal tract wall. In this report we present a case of gastrointestinal stromal tumors with mesenteric and retroperitoneal invasion, describe and discuss its computed tomography findings.
A 57-years-old male patient has been complaining of abdominal distention, weight lose, and hematuria. During physical examination, significant distention and multiple palpable tumor masses were identified on the abdomen. Abdominal computed tomography showed multiple, well-defined, soft tissue masses with homogenous and heterogeneous pattern, in the mesenteric and retroperitoneal areas. Unlike specific features of gastrointestinal stromal tumor, renal obstruction and atypical central calcification without chemotherapy that has not been yet described were seen in this case. Computed tomography did not reveal liver metastases and/or the lymph nodes with pathological size. Ultrasonography-guided true-cut® biopsy was made, histopathologic and immunohistochemical analyses demonstrated stromal tumor which, C-KIT (+). The patient underwent left ureterectomy, left nephrectomy and total colectomy. Postoperative histopathological analyses revealed lower grade malignant GISTs. As of 17 months after the surgery, he is alive and free of recurrence.
When intraabdominal, multiple, large (>5 cm), well-circumscribed, homogenous or heterogeneous mass lesions without ascites, omental caking and lymph nodes metasteses were seen, gastrointestinal stromal tumors should be considered in the differential diagnosis.
- Stromal Tumor
- Gastrointestinal Stromal Tumor
- Rectal Gist
- Muscularis Propria Layer
- Omental Caking
Gastrointestinal (GI) stromal tumor (GIST) is a rare visceral sarcoma arising in the gastrointestinal tract wall [1, 2]. This tumor arises in the muscularis mucosa and muscularis propria layers anywhere from the esophagus to the rectum. Its most common anatomic sites of origin are the stomach (60–70%), small intestine (20–30%), colon and rectum (5%), abdominal cavity, i.e. peritoneum and omentum (5%), esophagus (<5%) and retroperitoenal space (<3%) [3–5] In this report we present a rare case of multiple primary mesenteric and retroperitoneal GISTs, describe and discuss its computed tomography (CT) findings.
Postoperative histopathological analyses revealed that the tumor was total 25 cm in diameter. It was composed of spindle-shaped cells with hemorrhagic areas. Mitotic activity was 3 mitoses per 50 HPF. The tumor invaded the small bowel serosa, colonic submucosa and the left ureter. Thus the tumor was not described as an extra-GIST that arose from the soft tissue of the abdominal cavity (omentum and mesentery) and retroperitoneum because of the existance of an attachment of serosa of GI tract . The tumor was described as a GIST with predominant mesenteric and retroperitoneal invasion and classified as a lower grade GIST according to Bucher grading system for GIST after surgical resection .
He had an uneventful postoperative course and was discharged home on postoperative day 3. As of 17 months after the surgery, he is alive and free of recurrence.
CT, magnetic resonance imaging (MRI) and fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) can be used for evaluation of GIST. Contrast-enhanced CT scan is, however, more widely available and is currently the imaging modality of choice for patients with suspected abdominal mass or biopsy-proven GIST. CT is used in staging and surgical planning. When a small tumor is found incidentally during endoscopy, the local extent of the tumor should be evaluated using either endoscopic ultrasound or CT. For those with known or suspected rectal GIST, a dedicated MRI provides better information than CT scan in preoperative staging work-up. Evaluation of FDG uptake using PET scanning is recommended when an early detection of tumor response to imatinib treatment is required .
CT findings of GISTs are well described in the radiological literature [8–13]. Malignant GISTs are typically extraluminal, large (>5 cm), well-circumscribed, heterogeneous, centrally necrotic tumors. Such features contrast with the regular contours, homogeneous density, and intraluminal growth patterns that are characteristic of smaller benign GISTs. Thus, well-circumscribed tumors appear to be a feature of GISTs, as in our case, on CT imaging. Heterogeneous density, on the other hand, was independent from tumor dimension. Heterogeneous density, pathologically concordant with hemorrhage, has been found in tumors less than 5 cm, despite the homogeneous densities found in the tumors bigger than 5 cm.
Exceptional to the reports published so far, Takao et al., reported a GIST of the peripancreatic retroperitoneum with CT and MR imaging findings representing huge well-defined inhomogeneous mass with peripheral calcification . In our case, atypical central course calcification without chemotherapy that has not been yet described, were seen in only one mass.
The spread pattern of these tumors shows predilection for liver metastasis and peritoneal dissemination . In that case, however, concordant with the results of a few studies published previously, the relationship between multiple tumors and metastasis was not seen. No liver or lymph node metastasies have been seen in spite of multiple malign stromal tumor masses [5, 11].
Burkill et al., reported that stromal tumors rarely obstruct viscera, despite their large size . In our case, no small bowel or colonic obstruction findings have been found in spite of the proximity of mesenteric multiple mass lesions to the colon, – especially descending colon-. However, in that case, there is a hydronephrosis due to ureteral obstruction which is a very rare finding. In the report of Burkill et al., 116 malignant GIST were analyzed, and only one case has this behavior .
In our case, we have seen multiple peritoneal tumor masses without peritoneal fluid. Burkill, et al., concordantly with our case, reported that ascites and omental caking were unusual findings in stromal tumors .
Tumor size, anatomic location, and mitotic count are considered independent prognostic factors for GISTs [15, 16], and tumors that measure ≥5 cm are associated with an unfavorable prognosis. The anatomic site of origin of a GIST is associated strongly with its clinical behavior, and patients who have tumors that arise in the rectum or small intestine have the worst prognosis compared with the more favorable outcomes observed among patients who have esophageal and gastric neoplasms . Likewise, GISTs that exhibit ≥5 mitoses per 50 HPF or ≥2 mitotic figures per 10 HPF are associated with an unfavorable prognosis regardless of their site of origin [15, 17–22]. Our case had multiple mesenteric and retroperitoneal stromal tumors; mitoses were < 5 per 50 HDI, total tumor diameter was 25 cm. The localization was unfavorable but bad prognostic signs such as liver or lymph node metastases were not seen.
The differential diagnosis of an abdominal mass with well defined, extraluminal masses and homogeneous enhancement in the abdominal cavity includes peritoneal implants, lymphoma, primary peritoneal carcinomatosis, carcinoids, and other soft-tissue tumors (leiomyosarcoma, malignant tumors of nerve sheath and vascular origin) [10, 12, 23]. In our case, absence of peritoneal ascites and omental caking excluded peritoneal implant and primary peritoneal carcinomatosis, absence of lymph node metastases excluded lymphoma diagnosis. For definitive diagnosis, US-guided true-cut® biopsy and then histopathologic and immunohistochemical analyses were made. However, preoperative percutaneous biopsy carries a theoretical risk of peritoneal seeding or tumor rupture, and is indicated only for clearly irresectable disease or when treatment needs to be altered, as would be the case if the mass proved to be lymphoma or germ cell tumor . One alternative technique is endoscopic US-fine needle aspiration (FNA), which has been used increasingly for the evaluation of different types of intraabdominal and intrathoracic lesions. Observations to date indicate that endoscopic US-FNA is a safe and accurate procedure .
Immunoreactivity for CD117 (C-KIT) is a characteristic of GISTs; in addition, most GISTs express CD34 immunostain. Another marker that is considered useful in the assessment of GISTs is Ki-67 immunostain, with reported 100% specificity and sensitivity for malignancy on GISTs . Immunohistochemical studies on that tumor cells revealed positive staining for C-KIT (CD117), whereas CD34, antibodies against smooth-muscle actin (SMA), desmin, actine and S-100 protein were negative.
When intraabdominal, multiple, large (>5 cm), well-circumscribed, homogenous or heterogeneous mass lesions without ascites, omental caking and lymph nodes metasteses were seen, GIST should be considered in the differential diagnosis.
Written informed consent was obtained from the patient for publication of this case report.
- Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with reference to CD117 (kit). Mod Pathol. 2000, 3: 1134-1142. 10.1038/modpathol.3880210.View ArticleGoogle Scholar
- Stelow EB, Stanley MW, Mallery S, Lai R, Linzie BM, Bardales RH: Endoscopic ultrasound-guided fine needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol. 2003, 119: 703-708. 10.1309/UWUV-Q001-0D9W-0HPN.View ArticlePubMedGoogle Scholar
- Lewis JJ, Leung D, Woodruff JM, Brennan MF: Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated andfollowed at a single institution. Ann Surg. 1998, 228: 355-365. 10.1097/00000658-199809000-00008.PubMed CentralView ArticlePubMedGoogle Scholar
- Reith JD, Goldblum JR, Lyles RH, Weiss SW: Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000, 13: 577-585. 10.1038/modpathol.3880099.View ArticlePubMedGoogle Scholar
- Urbanczyk K, Limon J, Korobowicz E, Chosia M, Sygut J, Karcz D, Iwanik K, Osuch C, Lasota J, Stachura J: Gastrointestinal stromal tumors. A multicenter experience. Pol J Pathol. 2005, 56: 51-61.PubMedGoogle Scholar
- Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, Buhler LH, Morel P: An audit of surgical management of gastrointestinal stromal tumors (GIST). Eur J Surg Oncol. 2006, 32: 310-314. 10.1016/j.ejso.2005.11.021.View ArticlePubMedGoogle Scholar
- Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD: GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March under the auspices of ESMO. Ann Oncol. 2005, 16: 566-578. 10.1093/annonc/mdi127.View ArticlePubMedGoogle Scholar
- Ghanem N, Altehoefer C, Furtwangler A, Winterer J, Schäfer O, Springer O, Kotter E, Langer M: Computed tomography in gastrointestinal stromal tumors. Eur Radiol. 2003, 13: 1669-1678. 10.1007/s00330-002-1803-6.View ArticlePubMedGoogle Scholar
- Hersh MR, Choi J, Garrett C, Clark R: Imaging gastrointestinal stromal tumors. Cancer Control. 2005, 12: 111-115.PubMedGoogle Scholar
- Burkill GJC, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C, Moskovic EC: Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology. 2003, 226: 527-532. 10.1148/radiol.2262011880.View ArticlePubMedGoogle Scholar
- Lee CM, Chen HC, Leung TK, Chen YY: Gastrointestinal stromal tumor: computed tomographic features. World J Gastroenterol. 2004, 10: 2417-2418.View ArticlePubMedGoogle Scholar
- Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C: Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics. 2006, 26: 481-495. 10.1148/rg.262055097.View ArticlePubMedGoogle Scholar
- Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD: Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol. 2005, 15: 1407-1414. 10.1007/s00330-005-2647-7.View ArticlePubMedGoogle Scholar
- Takao H, Yamahira K, Doi I, Watanabe T: Gastrointestinal stromal tumor of the retroperitoneum: CT and MR findings. Eur Radiol. 2004, 14: 1926-1929. 10.1007/s00330-004-2404-3.View ArticlePubMedGoogle Scholar
- Cunningham RE, Federspiel BH, McCarthy WF, Sobin LH, O'Leary TJ: Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol. 1993, 17: 588-594. 10.1097/00000478-199306000-00006.View ArticlePubMedGoogle Scholar
- Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependence on anatomic site. Am J Surg Pathol. 1999, 23: 82-97. 10.1097/00000478-199901000-00009.View ArticlePubMedGoogle Scholar
- Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J: Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000, 24: 211-222. 10.1097/00000478-200002000-00007.View ArticlePubMedGoogle Scholar
- Tworek JA, Appelman HD, Singleton TP, Greenson JK: Stromal tumors of the jejunum and ileum. Mod Pathol. 1997, 10: 200-209.PubMedGoogle Scholar
- Brainard JA, Goldblum JR: Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. Am J Surg Pathol. 1997, 21: 407-416. 10.1097/00000478-199704000-00006.View ArticlePubMedGoogle Scholar
- Tworek JA, Goldblum JR, Weiss SW, Greenson JK, Appleman HD: Stromal tumors of the abdominal colon. Am J Surg Pathol. 1999, 23: 937-945. 10.1097/00000478-199908000-00012.View ArticlePubMedGoogle Scholar
- Haque S, Dean PJ: Stromal neoplasms of the rectum and anal canal. Hum Pathol. 1992, 23: 762-767. 10.1016/0046-8177(92)90345-4.View ArticlePubMedGoogle Scholar
- Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001, 25: 1121-1133. 10.1097/00000478-200109000-00002.View ArticlePubMedGoogle Scholar
- Sandrasegaran K, Rajesh A, Rydberg J, Rushing DA, Akisik FM, Henley JD: Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features. AJR. 2005, 184: 803-811.View ArticlePubMedGoogle Scholar
- Connolly EM, Gaffney E, Reynolds JV: Gastrointestinal stromal tumours. Br J Surg. 2003, 90: 1178-1186. 10.1002/bjs.4352.View ArticlePubMedGoogle Scholar
- Akahoshi K, Sumida Y, Matsui N, Oya M, Akinaga R, Kubokawa M, Motomura Y, Honda K, Watanabe M, Nagaie T: Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol. 2007, 13: 2077-2082.PubMed CentralPubMedGoogle Scholar
- Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T, Hayakawa T: The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc. 2002, 55: 37-43. 10.1067/mge.2002.120323.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.